Literature DB >> 2743281

Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases.

Y Gagnon1, B Têtu.   

Abstract

Of 165 ovarian metastases recorded in the files of L'Hôtel-Dieu de Québec, Canada, between 1951 and 1987, 64 (38%) were from breast adenocarcinomas. Histopathologic material was available in 59 instances, of which 22 were autopsy cases and 28 were incidental findings at therapeutic oophorectomy. The patients' ages ranged from 25 to 80 years (average, 48.6 years). Sixty-four percent of the metastases were bilateral and 36% were unilateral. An ovarian metastasis was detected before the breast cancer in only one instance. The median interval between the diagnosis of breast carcinoma and the ovarian metastasis was 11.5 months and was related to the initial stage of the breast disease. The median survival after the diagnosis of ovarian metastasis was 16 months. The ovaries were grossly normal in 27 (46%) cases and 18 (31%) metastases were less than 1 mm in diameter. The size of the metastases was not related to the interval after the diagnosis of the breast carcinoma and did not influence the outcome of the patients. Forty-four metastases (75%) showed an indian file or ductal patterns easily identifiable as metastases of breast origin. The remaining cases presented various histologic features mimicking primary ovarian tumors or tumor-like conditions such as stromal luteoma, hyperthecosis, dysgerminoma, granulosa cell tumor, and carcinoid tumor. No metastasis had features of Krukenberg tumor. The authors conclude that metastases from breast cancer are generally small and are the reflection of an advanced disease. A metastasis of breast origin can be suspected histologically in most cases.

Entities:  

Mesh:

Year:  1989        PMID: 2743281     DOI: 10.1002/1097-0142(19890815)64:4<892::aid-cncr2820640422>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study.

Authors:  V Luyckx; J F Durant; A Camboni; S Gilliaux; C A Amorim; A Van Langendonckt; L M Irenge; J L Gala; J Donnez; M M Dolmans
Journal:  J Assist Reprod Genet       Date:  2013-08-29       Impact factor: 3.412

2.  Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.

Authors:  J H Lagendijk; H Mullink; P J van Diest; G A Meijer; C J Meijer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

Review 3.  Fertility preservation in women.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Nat Rev Endocrinol       Date:  2013-10-29       Impact factor: 43.330

4.  Ovarian metastasis from breast cancer mimicking a primary ovarian neoplasm: A case report.

Authors:  Yoshika Akizawa; Toshiyuki Kanno; Yu Horibe; Yumi Shimizu; Eiichiro Noguchi; Tomoko Yamamoto; Takahiro Okamoto; Yoji Nagashima; Tsutomu Tabata
Journal:  Mol Clin Oncol       Date:  2021-05-17

5.  An ovarian mass after breast cancer: Metachronous carcinoma or metastasis? A case report.

Authors:  Georgios-Marios Makris; Alexandros Marinelis; Marco-Johannes Battista; Charalampos Chrelias; Nikolaos Papantoniou
Journal:  Int J Surg Case Rep       Date:  2016-12-30

6.  The use of laparoscopic rectopexy to manage rectal prolapse with Pseudo-Meigs' syndrome in a 64-year-old female: a case report.

Authors:  Takayuki Kondo; Masashi Tsuruta; Hirotoshi Hasegawa; Koji Okabayashi; Kohei Shigeta; Tetsu Hayashida; Yuko Kitagawa
Journal:  Clin Case Rep       Date:  2017-03-29

7.  Morphological and phenotypical features of ovarian metastases in breast cancer patients.

Authors:  Inge T A Peters; Merle A van der Steen; Bertine W Huisman; Carina G J M Hilders; Vincent T H B M Smit; Alexander L Vahrmeijer; Cornelis F M Sier; J Baptist Trimbos; Peter J K Kuppen
Journal:  BMC Cancer       Date:  2017-03-21       Impact factor: 4.430

8.  Measurable Krukenberg tumor is preferably characterized as a non-target lesion in the clinical evaluation of gastric cancer therapeutics: A case report.

Authors:  Bi-Cheng Wang; Chen Fu; Jun-Li Liu; Yu-Ting Li; Tao Zhang; Gang Wu; Quentin Liu; Jun Xue
Journal:  Mol Clin Oncol       Date:  2018-10-08

9.  Incidental diagnosis of breast cancer in the pursuit of the treatment of intestinal obstruction.

Authors:  Isabel Armas; Mariana Brandão; Inês Guerreiro; Inês Guerreiro; João Lobo; Carla Freitas; João Pinto-de-Sousa; Joaquim Abreu de Sousa
Journal:  Autops Case Rep       Date:  2019-02-25

10.  A case of pseudo-meigs' syndrome associated with ovarian metastases from breast cancer.

Authors:  Koma Naito; Shoji Oura; Hironao Yasuoka; Yoshitaka Okamura
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.